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Background/Aims: Most patients with acute viral hepatitis A have a favorable course, but a few of them suffer from severe forms 
of hepatitis such as fulminant hepatitis. This study was carried out to identify the factors influencing the severity of acute viral 
hepatitis A. Methods: We retrospectively reviewed the medical records of 713 patients with acute hepatitis A, who were divided 
into two groups: severe hepatitis A (N=87) and non-severe hepatitis A (N=626). Severe hepatitis was defined as fulminant 
hepatitis or prolongation of prothrombin time (INR≥1.5). Clinical variables were compared between the two groups. Results: The 
incidence of fulminant hepatitis was 1.4 % (10/713) in patients with acute hepatitis A. Thirty-three (4.6 %) cases exhibited HBsAg 
positivity. In multivariate analyses, significant alcohol intake and the presence of HBsAg were significant predictive factors of 
fulminant hepatitis A, and significant alcohol intake and age were significant predictive factors of severe hepatitis A. HBeAg and 
HBV-DNA status did not affect the clinical course of hepatitis A in chronic hepatitis B carriers. Conclusions: While most patients 
with acute hepatitis A have an uncomplicated clinical course, our data suggest that a more-severe clinical course is correlated 
with being older, significant alcohol intake, and chronic hepatitis-B-virus infection. (Korean J Hepatol 2010;16:295-300)
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INTRODUCTION
Hepatitis A is mostly self-limited acute illness and does not 
progress to chronic hepatitis. In children, hepatitis A virus (HAV) 
infection is usually asymptomatic whereas symptomatic in 
adults, and also it rarely develop fulminant hepatitis or accompany 
serious complication such as acute renal failure.
1,2 According to 
epidemiological research in Korea, anti-HAV positivity increases 
after birth and becomes 50% around age 10 and most adults had 
anti-HAV in early 1980s.
3 However, after 1990s, with improving 
standard of living and personal hygiene, anti-HAV positivity in 
children has decreased significantly resulting in rapid increase of 
adult hepatitis A infection; 355 in 2004, 2,081 in 2006 and 7,895 
in 2008.
4,5
Factors influencing on the severity of viral hepatitis A consist 
of host and viral factors. For the host factors, chronic liver disease, 
old age, heavy alcohol drinking, human immunodeficiency virus 
(HIV) infection and pregnancy are being suggested.
2,6-13 It has 
been reported that when hepatitis A is superimposed on chronic 
hepatitis C, it frequently shows critical clinical course and 
accompany high rate of fulminant hepatitis and mortality.
10 
However, the affect of hepatitis B virus (HBV) infection on the 
severity of viral hepatitis A differs among researches.
10,14-17
This study was carried out to identify the factors influencing 
on the severity of hepatitis A by analyzing several factors 
including underlying chronic HBV infection.
PATIENTS AND METHODS
1. Subjects and definitions
We retrospectively reviewed the medical records of 713 
patients with acute hepatitis A from June 2006 to May 2009. 
Diagnosis of acute hepatitis A was made by positive serum IgM 296  The Korean Journal of Hepatology Vol. 16. No. 3, September 2010
Table 1. Comparison of clinical features between the patients with fulminant and non-fulminant hepatitis
FH (n=10) Non-FH (n=703) P-value
Age (yr) 35.4±8.9 31.0±6.6 0.044
*
Male (%) 9 (90) 404 (57) 0.050
†
Diabetes mellitus (%) 0 (0) 5 (0.7) 1.000
†
Significant alcohol intake (%) 2 (20.0) 23 (3.3) 0.045
†
HBsAg positivity (%) 4 (40.0) 29 (4.1) 0.001
†
Anti-HCV positivity (%) 0 (0) 4 (0.6) 1.000
†
Total bilirubin (mg/dL) 23.8±16.6 7.0±3.9 <0.001
*
Albumin (g/dL) 2.3±0.6 3.5±0.4 <0.001
*
AST (IU/L) 5,173±2,786 2,578±2,447 0.005
*
ALT (IU/L) 4,693±2,668 3,099±2,009 0.044
*




3) 70±55 176±77 <0.001
*
Creatinine (mg/dL) 3.5±2.5 1.0±1.1 <0.001
*
Hospital stay (days) 26±28 9±4 0.020
*
All results were presented as n (%) or mean±SD.
P-value was obtained by 
*Mann-whitney U test or 
†Fisher’s exact test.
FH, fulminant hepatitis; HBsAg, hepatitis B surface antigen; Anti-HCV, antibody to hepatitis C; AST, aspartate aminotransferase; 
ALT, alanine aminotransferase; INR, international normalized ratio.
Table 2. Multivariable analysis of predictive factors associated with fulminant hepatitis
Odds ratio (95% CI) P-value
*
HBsAg positivity 22.448 (5.346-94.270) <0.001
Significant alcohol intake 14.152 (2.465-81.243) 0.003
Male 0.195 (0.023-1.647) 0.133
Age (yr) 1.064 (0.965-1.173) 0.211
* Multiple logistic regression analysis.
CI, confidence interval; HBsAg, hepatitis B surface antigen.
anti-HAV (radio-Immunoassay, General Biologicals Corp., Hsin 
Chu, Taiwan), and hepatitis B and hepatitis C by testing HBsAg 
(RIAKEY, Shin Jin Medics. Inc., Korea), anti-HBs (RIAKEY, 
Shin Jin Medics. Inc., Korea), and anti-HCV (RIAKEY, Shin Jin 
Medics. Inc., Korea). Significant alcohol intake was defined as 
more than 50 g of alcohol for over 10 years.
18 Fulminant hepatitis 
was defined as progression to hepatic encephalopathy within 8 
weeks from the onset of jaundice, and severe hepatitis (SH) was 
defined as fulminant hepatitis or prolongation of prothrombin 
time (INR) over 1.5.
19
2. Methods
A total of 713 patients were divided into two groups; ful-
minant hepatitis (FH) and non-fulminant hepatitis (Non-FH). 
Each group was analyzed by age, sex, superimposed hepatitis B 
or hepatitis C, diabetes mellitus, significant alcohol intake, dura-
tion of hospital stay and complete blood count, serum bio-
chemistry and coagulation test at most severe clinical course. In 
addition, we divided the subjects into severe hepatitis (SH) and 
non-severe hepatitis (Non-SH) to analyze for the same factors to 
identify the risk factors of fulminant and severe hepatitis caused 
by hepatitis A.
3. Statistical analysis
Statistical analysis were performed using SPSS (version 12.0, 
SPSS Inc., Chicago, IL). To compare baseline variables. Fisher’s 
exact test was used for categorical variables and Mann-Whitney 
U test and independent t-test were used for continuous variables. 
Also, to identify the related risk factors for fulminant hepatitis 
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Table 3. Comparison of clinical characteristics between the patients with severe hepatitis and non-severe hepatitis 
SH (n=87) Non-SH (n=626) P-value
Age (yr) 33.5±6.3 30.7±6.6 <0.001
*
Male (%) 60 (69.0) 353 (56.4) 0.028
†
Diabetes mellitus (%) 2 (2.3) 3 (0.5) 0.115
†
Significant alcohol intake (%) 8 (9.2) 17 (2.7) 0.007
†
HBsAg positivity (%) 8 (9.2) 25 (4.0) 0.050
†
Anti-HCV positivity (%) 0 (0) 5 (0.8) 1.000
†
Total bilirubin (mg/dL) 10.4±8.2 6.8±3.8 0.001
*
Albumin (g/dL) 3.1±0.4 3.5±0.4 <0.001
*
AST (IU/L) 5,470±2,512 2,217±2,187 <0.001
*
ALT (IU/L) 5,371±2,075 2,809±1,811 <0.001
*




3) 127±61 181±77 <0.001
*
Creatinine (mg/dL) 1.9±2.6 0.9±0.8 0.001
*
Hospital stay (days) 14±12 9±4 0.001
*
Severe hepatitis was defined as fulminant hepatitis or prothrombin time (INR) over 1.5.
All results were presented as n (%) or mean±SD.
P-value was obtained by 
*Independent  t-test or 
†Fisher’s exact test.
FH, fulminant hepatitis; SH, severe hepatitis A; HBsAg, hepatitis B surface antigen; Anti-HCV, antibody to hepatitis C; AST, 
aspartate aminotransferase; ALT, alanine aminotransferase; INR, international normalized ratio.
Table 4. Multivariate analysis of predictive factors associated with severe hepatitis A
Odds ratio (95% CI) P-value
*
HBsAg positivity 2.295 (0.984-5.353) 0.055
Significant alcohol intake  2.947 (1.203-7.221) 0.018
Male 0.662 (0.404-1.087) 0.103
Age (yr) 1.053 (1.018-1.089) 0.003
Severe hepatitis was defined as fulminant hepatitis or prothrombin time (INR) over 1.5.
* Multiple logistic regression analysis.
CI, confidence interval; FH, fulminant hepatitis; INR, international normalized ratio; HBsAg, hepatitis B surface antigen.
analysis of variables that were significant in univariate analysis. 
Statistical significance was assumed at p<0.05.
RESULTS
1. Clinical features of the subjects
Mean age of the patients was 31.1 (±6.8) years, 413 (57.9%) 
patients were male, 300 (42.1%) patients were female. Duration 
of hospital stay was 9.6 days. Severe hepatitis occurred in 87 
(12.2%) patients and 10 (1.4%) of these patients had fulminant 
hepatitis. Of the patients with fulminant hepatitis, 2 had liver 
transplantation, 4 recovered with medical treatment, 3 were 
expired due to liver failure and 1 expired due to pneumonia and 
systemic complication after liver transplantation. Chronic HBV 
carriers were 33 (4.6%), anti-HCV positive patients were 4, 
diabetes mellitus was in 5 cases and significant alcohol intake 
was in 25 cases.
2. Difference in clinical features of fulminant and
non-fulminant hepatitis
Age of fulminant and non-fulminant hepatitis group were 
35.4±8.9 and 31.0±6.6 years which showed significant 
difference (p=0.044). For each group, 90% and 57% (p=0.05) 
were male, indicating old age and male have significantly high 
rate of fulminant hepatitis. HBsAg positivity was 4 (40.0%) and 
29 (4.1%), thus it was significantly high in fulminant hepatitis 
group (p=0.001). Significant alcohol intake history was 2 
(20.0%) and 23 (3.3%) showing significantly high in fulminant 298  The Korean Journal of Hepatology Vol. 16. No. 3, September 2010
hepatitis group (p=0.045), whereas anti-HCV positivity 
(p=1.000) and diabetes mellitus (p=1.0) had no significant 
difference. Duration of hospital stay was longer in fulminant 
hepatitis group. Total bililubin, aspartate aminotransferase 
(AST), alanine aminotransferase (ALT), prothrombin time (INR) 
and creatinine were higher in fulminant hepatitis group, whereas 
albumin and platelet count were lower in fulminant hepatitis 
group (Table 1).
Multivariate analysis of age, sex, HBsAg positivity and 
significant alcohol intake history which are significant factors in 
univariate analysis of fulminant hepatitis group and non- 
fulminant hepatitis group were performed. As a result, HBsAg 
(OR 22.448, CI 5.346-94.270, p<0.001) and significant alcohol 
intake history (OR 14.152, CI 2.465-81.243, p=0.003) had 
significant correlation, whereas sex (OR 0.195, CI 0.023-1.647, 
p=0.133) and age (OR 1.064, CI 0.965-1.173, p=0.211) had no 
significant difference (Table 2).
3. Difference in clinical features of severe and 
non-severe hepatitis
Age of severe and non-severe hepatitis group were 33.5±6.3 
and 30.7±6.6 years (p<0.001) which showed significant 
difference, and 69.0% and 56.4% were male (p=0.028). HBsAg 
positivity was 8 (9.2%) and 25 (4.0%) indicating significance 
(p=0.050) and significant alcohol intake history was 8 (9.2%) 
and 17 (2.7%) showing significantly high in severe hepatitis 
group (p=0.007), whereas anti-HCV positivity (p=1.000) and 
diabetes mellitus (p=0.115) had no significant difference. Duration 
of hospital stay was longer in severe hepatitis group. Total 
bililubin, AST, ALT, prothrombin time (INR) and creatinine 
were higher in severe hepatitis group, whereas albumin and 
platelet count were lower in severe hepatitis group (Table 3). 
Multivariate analysis showed significant correlation in significant 
alcohol intake history (OR 2.947, CI 1.203-7.221, p=0.018) and 
age (OR 1.053, CI 1.018-1.089, p=0.003), and p-value of HBsAg 
positivity was 0.055 (Table 4).
4. Clinical features of hepatitis A in patients with 
chronic hepatitis B
Average age was 33.6±7.0 years, 22 (66.7%) were male, 11 
(33.3%) were female and duration of hospital stay was 15.1 days. 
Total bilirubin was 13.3±11.1 mg/dL, AST, 3,023±3,338 IU/L, 
ALT, 3,108±2,582 IU/L, prothrombin time (INR), 1.46± 0.64 
and creatinine was 1.5±2.4 mg/dL. HBeAg was positive in 5 
patients and their average serum HBV DNA concentration was 
1,553,832±5,655,405 copies/mL (310,766±1,131,081 IU/mL). 
Every patient was newly diagnosed as HBV carriers, thus medical 
records prior to the onset of acute hepatitis A were unfeasible. 
Among the 33 HBsAg positive patients, we compared the 
occurrence of fulminant hepatitis and severe hepatitis according 
to HBeAg positivity, however, there was no significant difference 
(p=0.500, p=1.000, respectively). In addition, we compared the 
incidence of fulminant hepatitis and severe hepatitis according to 
difference of serum HBV DNA concentration as groups more 
than 100,000 copies/mL (20,000 IU/mL) and less than 100,000 
copies/mL (20,000 IU/mL), and it also showed no statistical 
difference (p=0.420, p=0.571, respectively).
DISCUSSION
This study demonstrated that host and environmental factors 
affect the severity of liver disease in patients with acute hepatits 
A. Acute hepatitis A is mostly self-limited, thus in the past, 
fulminant hepatitis due to hepatitis A was considered rare in 
Korea. However, fulminant hepatitis from HAV is increasing 
constantly because of low anti-HAV positivity resulting in 
increased number of the patients in adolescents and young 
adults.
20,21 On the other hand, prevalence of fulminant hepatitis 
from hepatitis B is decreasing; therefore fulminant hepatitis from 
hepatitis A is increasing relatively.
22 Fulminant hepatitis from 
hepatitis A is known to occur in 0.1~0.3% of entire infection but 
it was high as 1.4% in this study which might be due to our 
institute that is tertiary referral hospital with liver transplant 
center.
Factors which affect the severity of viral hepatitis A consist of 
host and viral factors. For the viral factors, genetic variation of 5’ 
non-translated region (NTR) was related to the severity of the 
disease
8 whereas genotype of HAV had no relation to the severity 
of acute hepatitis A.
7,9
For the host factor, underlying chronic liver disease, old age, 
heavy alcohol drinking, HIV infection, pregnancy, etc. are being 
suggested. It is known to present critical clinical course when he-
patitis A is superimposed on preexisting chronic hepatitis. Vento 
et al. prospectively followed 432 patients with chronic hepatitis 
C and reported 7 out of patients developed fulminant hepatitis 
and 6 patients died. However in 163 patients with chronic hepatitis 
B, 10 acquired HAV superinfection and their clinical course was 
similar to that of uncomplicated courses of hepatitis A.
10 The 
results showed, unlike chronic hepatitis B who acquired an 
uncomplicated hepatitis A, patients with chronic hepatitis C had Joo Il Kim, et al. Factors influencing the severity of acute viral hepatitis A  299
a substantial risk of complicated course. In western countries, 
chronic hepatitis C with HAV superinfection is an issue since 
prevalence of hepatitis C is relatively higher than hepatitis B, but 
we have high prevalence of hepatitis B in Korea. According to a 
study in Thailand, chronic hepatitis B has significant affect on 
serious complication such as fulminant hepatitis or mortality. 
They reported 55% of fulminant hepatitis and 25% of mortality 
when HAV infection was superimposed on chronic hepatitis B.
17 
It also has been reported that chronic HBV carriers were 9 times 
more likely to develop fulminant hepatitis when they acquired 
acute hepatitis A.
16
There has been no domestic report on clinical course and 
prognosis of HAV superinfection on chronic HBV infection. In 
this study, we defined severe hepatitis A as fulminant hepatitis or 
prolongation of prothrombin time (INR) over 1.5.
19 When 
hepatitis A is superimposed on chronic hepatitis B patients, risk 
of fulminant hepatitis was 22.4 times higher and risk of severe 
hepatitis was also 2.3 times higher (p=0.055). Therefore, clinical 
course of the disease seems to be more fatal and severe in HBsAg 
positive patients. A possible mechanism causing more severe 
hepatitis in HBV carrier might be that the number of he-
patocytes has already been reduced in patients with chronic 
hepatitis B, thus when hepatitis A occurs, it can cause more 
severe liver damage. However, medical records on the activities 
and other prior conditions of chronic hepatitis B of the patients 
before they acquired hepatitis A were not available in this study 
and it might have affect on severity of the disease. Thus additional 
prospective study is needed for this concern. Since we had only 4 
patients with hepatitis C included in the research, our study did 
not show the difference in severity of hepatitis C acquired HAV 
superinfection unlike the result of Vento et al.
10
Age has been known as a risk factor for severe complication 
and mortality of hepatitis A,
23-25 and our study also concluded 
that the age is an independent factor for severe hepatitis by using 
multivariate analysis. In addition, we found alcohol intake as an 
independent factor in development of fulminant hepatitis; 
alcohol intake causes impairment in host defense system through 
changing cytokine formation and inducing reactive oxidation. 
Moreover, alcohol intake and viral hepatitis act synergistically 
on liver damage by inhibiting the liver regeneration and antiviral 
reaction with interferon-alpha.
26
When HIV patients acquire hepatitis A, HIV infection increases 
serum concentration of HAV and it also increase hepatitis A 
related liver damage.
6 It has been reported that hepatitis A in 
second to third trimester of pregnancy is related to maternal 
complication and preterm labor.
13 
This study has certain limitations; it showed high prevalence 
of fulminant hepatitis due to the characteristic of this institute 
which is tertiary hospital with liver transplant center, and 
majority of the subjects were referred patients with no prior 
record on earlier condition of the disease. Also, the number of 
subjects with fulminant hepatitis and severe hepatitis were small 
it has limits to determine statistical significance. Furthermore, 
the study lacks various patient histories since it was done 
retrospectively. To have accurate analysis on clinical features of 
acute hepatitis A and incidence of fulminant hepatitis, 
prospective, multi-institutional and more extensive studies are 
necessary.
In conclusion, although most patients with acute hepatitis A 
have uncomplicated clinical course, old age, significant alcohol 
intake, and underlying chronic HBV infection seems to be 
related with the development of fulminant or severe hepatitis in 
acute viral hepatitis A.
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